At a glance
ClinicalIndex Comparison Record- ✓HIV with CD4+ count >350 cells/mm³ for at least 2 years
- ✓On current antiretroviral (cART) regimen for at least 6 months
- ✓Mild to moderate cognitive impairment
- ✕Current or recent drug or alcohol abuse
- ✕History of Parkinson's disease
- ✕History of Alzheimer's disease
- ✕History of stroke or traumatic brain injury
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
The Effect of a Ketogenic Diet on HIV-Associated Neurocognitive Impairment
In Brief
A clinical study evaluating Ketogenic Diet for HIV and Neurocognitive Impairment. Completed, enrolled 17 participants across 1 site.
Detailed Summary
Randomized control pilot 12 week feeding trial to compare the preliminary effects of ketogenic diet (versus patient choice diet) on HIV-associated neurocognitive impairment. N = 20 (n = 10/10) randomized to diet condition. Pilot data necessary to evaluate the feasibility and determine initial data for primary outcomes in order to accurately determine needed sample size for larger clinical trial. Outcomes: 1) cognition (NIH Toolkit), 2) cardiometabolic markers (insulin glucose, insulin resistance, markers of inflammation), and 3) neural activity (as determined by functional MRI..
Study Details
Timeline
Interventions
12 week delivery of all meals/snacks (eucaloric) prepared by a registered dietician.